Acalabrutinib-Based Treatment Clinical Trial Updates

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic lymphocytic leukemia.

We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.

As I visit the cancer center for chemotherapy to treat my CLL, I can’t help but take note of how different cancer may look in each person.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.

During my chemotherapy treatments for chronic lymphocytic leukemia, I had a supportive group of people surrounding me.

It was beneficial for both myself and my loved ones when I gave a concrete answer to the question of “how can I help?”